Acotec Scientific Gets China's Registration Approval for Coronary Catheter

Like
Comment
Favorite

Acotec Scientific Gets China's Registration Approval for Coronary Catheter

MT Newswires Live2024-12-03

Acotec Scientific (HKG:6669) has obtained registration approval for the Paclitaxel-Eluting Coronary Balloon Dilatation Catheter AcoArt Camellia from China's National Medical Products Administration, a Tuesday bourse filing said.

The product is indicated for the treatment of de novo coronary artery lesions, according to the medical equipment maker.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

抱歉，当前请求异常(-1)

7x24

All

19:07
Heathrow Chairman Regrets Disruption Caused by Power Outage, Orders Former Transport Secretary Ruth Kelly to Undertake Internal Review
16:20
Reliance Discussed Selling Data Center Capacity to OpenAI and Meta - the Information
16:20
OpenAI Discussed Cutting Chatgpt Subscription Price Between 75% and 85% in India - the Information
16:20
OpenAI and Meta Seek AI Alliance With India’s Reliance - the Information
15:25
Britain's Energy Minister Commissions National Energy System Operator to Urgently Investigate Power Outage That Impacted Heathrow Airport and Surrounding Area, Government Says

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2488991312?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2024-12-03 19:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2488991312","market":"fut","top_or_hot":-1,"title":"Acotec Scientific Gets China's Registration Approval for Coronary Catheter","media":"MT Newswires Live","content":"<html><body><p> Acotec Scientific (HKG:6669) has obtained registration approval for the Paclitaxel-Eluting Coronary Balloon Dilatation Catheter AcoArt Camellia from China's National Medical Products Administration, a Tuesday bourse filing said.</p><p>The product is indicated for the treatment of de novo coronary artery lesions, according to the medical equipment maker.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Acotec Scientific Gets China's Registration Approval for Coronary Catheter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAcotec Scientific Gets China's Registration Approval for Coronary Catheter\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-12-03 19:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Acotec Scientific (HKG:6669) has obtained registration approval for the Paclitaxel-Eluting Coronary Balloon Dilatation Catheter AcoArt Camellia from China's National Medical Products Administration, a Tuesday bourse filing said.</p><p>The product is indicated for the treatment of de novo coronary artery lesions, according to the medical equipment maker.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06669","symbol_name":"先瑞达医疗-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2488991312","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2488991312","pubTimestamp":1733225896,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Acotec Scientific  has obtained registration approval for the Paclitaxel-Eluting Coronary Balloon Dilatation Catheter AcoArt Camellia from China's National Medical Products Administration, a Tuesday bourse filing said.The product is indicated for the treatment of de novo coronary artery lesions, according to the medical equipment maker.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06669":"先瑞达医疗-B","BK1587":"次新股","BK1100":"医疗保健设备","BK1574":"生物医药B类股"},"translate_title":"先瑞达科技获得中国冠脉导管注册批件","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06669":0.9},"content_text":"Acotec Scientific (HKG:6669) has obtained registration approval for the Paclitaxel-Eluting Coronary Balloon Dilatation Catheter AcoArt Camellia from China's National Medical Products Administration, a Tuesday bourse filing said.The product is indicated for the treatment of de novo coronary artery lesions, according to the medical equipment maker.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}